Author

I. J. Majewski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

C. L. Scott· 1 shared C. Vandenberg· 1 shared E. Lieschke· 1 shared Z. Xu· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. L. Scott

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CHK2 inhibition provides a strategy to suppress hematological toxicity from PARP inhibitors.

Z. Xu, C. Vandenberg, E. Lieschke, C. L. Scott, I. J. Majewski

This study identifies CHK2 inhibition as a strategy to reduce hematological toxicity from PARP inhibitors by targeting the p53 pathway in blood cells.

bioRxiv · Jul 28, 2020Cancer Biology